/Investors

What If Ventures — 2024 Investments

3 investments dated 2024 · listed companies and verified rows first · show all

Alto Pharmacyalto.comin𝕏Nov 2024

Alto Pharmacy is a full-service pharmacy that offers patients medication delivery, cost transparency, and pharmacist access.

ConsumerDigital HealthHealthtechSan Francisco, US

James Karraker(Executive Officer, Director)Mattieu Gamache-Asselin(Founder & CEO)inNichola Eliovits(Director)inNathaniel Kan(Director)Robert Spinner(Director)

BoardNeil Shah(Director)in

PartnerStephen Hays· solo GP

Co-investorsAvego BioScience CapitalBantam GroupCalm VenturesCSC UpshotEvolution VC PartnersFlucas Ventures+10 more

Q Bio, Inc.q.bioJul 2024 · $27M

Q.bio provides quantitative biology assessments and longitudinal health monitoring for preventive care, offering comprehensive measurable exams at the scale of premium care providers.

AI & Machine LearningBiotechDigital HealthHealthtechSan Carlos, US

Jeffrey Kaditz(Executive Officer, Director, Promoter)Clarissa Shen(Executive Officer)

BoardTerry Doyle(Director)Vijay Pande, Ph.D.(Director)

Co-investorsAndreessen HorowitzBeast VenturesEvolution VenturesMana Ventures

Terray Therapeuticsterraytx.aiin𝕏Series B · Oct 2024 · $120M

Terray is a drug discovery company that combines proprietary hardware, large-scale experimental datasets, and AI through its EMMI platform to design small molecule medicines.

AI & Machine LearningBiotechDeep Tech

Eli Berlin(Founder)in

BoardChris PicardoinDusan PerovicinSid ShenaiinSamuel BjorkinBassil Dahiyat, Ph.D.

Co-investorsDeviation CapitalDigitalis VenturesMadrona Venture GroupSummit Peak InvestmentsAlexandriaKdT Ventures+5 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.